A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): Interim analysis on 199 patients-The TOPNIVO study on behalf of the GORTEC and the Unicancer Head & Neck

Affiliation auteurs!!!! Error affiliation !!!!
TitreA safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): Interim analysis on 199 patients-The TOPNIVO study on behalf of the GORTEC and the Unicancer Head & Neck
Type de publicationJournal Article
Year of Publication2019
AuteursEven C, Daste A, Saada-Bouzid E, Lefebvre G, Fayette J, Zanetta S, Kaminsky M-C, Cupissol D, Prevost A, Vauleon E, Johnson AClaire, Salas S, Rolland F, David MTimar, Jallut I, Delaye J, Bourhis J, Guigay J, Texier M, Auperin A
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.15_suppl.6032